Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma

The aim of this paper is to explore the efficacy of whole brain radiotherapy (WBRT) versus WBRT concurrent with erlotinib in patients with multiple brain metastases of lung adenocarcinoma. WBRT was administered at 30Gy/10f in both arms. In the combination arm, 150 mg erlotinib was given each day, st...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhuang, Hongqing, Yuan, Zhiyong, Wang, Jun, Zhao, Lujun, Pang, Qingsong, Wang, Ping
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3797237/
https://ncbi.nlm.nih.gov/pubmed/24133369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S53011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars